CIK 0001818382 · Non-accelerated filer<br>Smaller reporting company
Humacyte, Inc.
Sign in to watch- Ticker
- HUMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851763759
- Phone
- 919-313-9633
- Business address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
- Former names
- Alpha Healthcare Acquisition Corp.
- Open-market buys, last 90 days
- $30,370
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$30,370. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-13 | Jones Keith Anthony Director | Grant or award · Stock Options (right to buy) | +75,000 | 75,000 | ||
| 2024-06-13 | Green Charles Bruce Director | Grant or award · Stock Options (right to buy) | +50,000 | 50,000 | ||
| 2024-06-13 | Dougan Brady W Director | Grant or award · Stock Options (right to buy) | +50,000 | 50,000 | ||
| 2024-06-13 | Constantino Michael T. Director | Grant or award · Stock Options (right to buy) | +50,000 | 50,000 | ||
| 2024-06-13 | Brown Emery N. Director | Grant or award · Stock Options (right to buy) | +50,000 | 50,000 | ||
| 2024-06-13 | Bamforth John Philip Director | Grant or award · Stock Options (right to buy) | +75,000 | 75,000 | ||
| 2024-06-12 | Niklason Laura E President, CEO and Director | Sale | −271,518 | $7.30 | $2.0M | 4,559,140 |
| 2024-06-12 | Dougan Brady W Director | Sale | −271,518 | $7.30 | $2.0M | 4,559,140 |
| 2024-06-11 | Niklason Laura E President, CEO and Director | Sale | −282,000 | $7.09 | $2.0M | 4,907,288 |
| 2024-06-11 | Niklason Laura E President, CEO and Director | Sale | −76,630 | $7.02 | $538K | 4,830,658 |
| 2024-06-11 | Dougan Brady W Director | Sale | −282,000 | $7.09 | $2.0M | 4,907,288 |
| 2024-06-11 | Dougan Brady W Director | Sale | −76,630 | $7.02 | $538K | 4,830,658 |
| 2024-06-04 | Niklason Laura E President, CEO and Director | Purchase | +2,362 | $6.35 | $15K | 240,832 |
| 2024-06-04 | Dougan Brady W Director | Purchase | +2,362 | $6.35 | $15K | 240,832 |
| 2024-06-04 | Niklason Laura E President, CEO and Director | Sale | −1,852 | $7.28 | $13K | 5,189,288 |
| 2024-06-04 | Dougan Brady W Director | Sale | −1,852 | $7.28 | $13K | 5,189,288 |
| 2024-06-03 | Niklason Laura E President, CEO and Director | Sale | −190,214 | $7.42 | $1.4M | 5,191,140 |
| 2024-06-03 | Dougan Brady W Director | Sale | −190,214 | $7.42 | $1.4M | 5,191,140 |
| 2024-06-03 | Niklason Laura E President, CEO and Director | Purchase | +2,050 | $7.37 | $15K | 238,470 |
| 2024-06-03 | Dougan Brady W Director | Purchase | +2,050 | $7.37 | $15K | 238,470 |
Page 6 of 17 · 330 trades